Scientists come closer to ‘synthetic life’ in lab

London, Aug 21 (ANI): A group of scientists has created a new “engineered” strain of bacteria – a development which could be described as a step towards the creation of “synthetic life”.

The team, including scientist J Craig Venter, a leading figure in the controversial field of synthetic biology, has successfully transferred the genome of one type of bacteria into a yeast cell, modified it, and then transplanted into another bacterium.

The study paves the way to the creation of a synthetic organism – inserting a human-made genome into a bacterial cell.

It has been described in the journal Science.

According to boffins, the advancement overcomes the obstacle of making a new inserted genome work inside a recipient cell.

The resulting cell Sanjay Vashee, one of the authors, and his team created went on to undertake multiple rounds of cell division, to produce a new strain of the modified bacteria.

Vashee is a researcher at the J. Craig Venter Institute in Rockville, Maryland, in the US. He explained to BBC News: “Bacteria have ‘immune’ systems that protect them from foreign DNA such as those from viruses.”

The scientists disabled the immune system, which consists of proteins called restriction enzymes that home in on specific sections of DNA and chop up the genome at these points.

Bacteria can shield their own genomes from this process by attaching chemical compounds called methyl groups at the points which the restriction enzymes attack.

The scientists modified the original genome of the bacterium Mycoplasma mycoides, whilst it was inside the yeast cell. Then they either attached methyl groups to it, or inactivated the restriction enzyme of the recipient bacterium, before transplanting the genome into its new cell.

The team aims to transplant a fully synthetic genome into a bacterial cell – creating bacteria that can be programmed to carry out specific functions – for example, digesting biological material to produce fuel. (ANI)

Gene in breast cancer pathway identified

Washington, May 13 (ANI): In a new study, scientists at Albert Einstein College of Medicine of Yeshiva University have unravelled a mechanism responsible for turning on and off a gene crucial to breast cancer spread.

Einstein scientists had previously discovered a gene called ZBP1 (zipcode binding protein 1), which helps cells to move, grow and organize spatially.

“ZBP1 is very active in the developing embryo but largely silent in adult tissues,” said Dr Robert H. Singer, professor and co-chair of anatomy and structural biology and co-director of the Gruss-Lipper Biophotonics Center at Einstein.

This gene has been found active in several types of cancer, including breast, colorectal, and non-small cell lung cancers; but the gene is silenced in metastasizing cancer cells.

In the new study, Singer and another Einstein scientist, Dr John Condeelis sought to determine how ZBP1 gene is activated and silenced and how it influences the spread of breast cancer.

The find may offer potential drug targets for preventing metastasis.

After examining mouse, rat, and human breast cancer cells, they found that ZBP1 silencing occurs when a methyl group (CH3) attaches to ZBP1′s promoter region (the segment of a gene where gene expression is initiated).

The attachment of CH3 prevents the promoter from binding to a protein called beta-catenin. And without beta-catenin, the ZBP1 gene is effectively silenced.

The study showed that the silencing of ZBP1 increases cancer cells’ ability to migrate and promotes the proliferation of metastatic cells.

The researchers claim that the study has important implications for forecasting breast cancer outcomes.

They said that signs of ZBP1 silencing in breast cancer cells would indicate that a breast tumour is likely to spread information that would help in choosing a treatment strategy.

“If you could turn on this protein in cancer cells, or prevent it from being turned off, you could seriously reduce the ability of the cells to metastasize,” said Singer.

The study appears in the Journal of Cell Science. (ANI)

Genetic changes outside nuclear DNA may trigger half of all cancers

Washington, Mar 25 (ANI): Johns Hopkins scientists have said that genetic changes outside nuclear DNA may lead to over fifty percent of all cancers.

Already, it is known that a process known as hypermethylation, which is a buildup of chemical bonds on certain cancer-promoting genes, can render cells cancerous by disrupting biological brakes on runaway growth.

And now, scientists have claimed that the reverse process – demethylation – which wipes off those chemical bonds may also trigger more than half of all cancers.

One potential consequence of the new research is that demethylating drugs now used to treat some cancers may actually cause new cancers as a side effect.

“It’s much too early to say for certain, but some patients could be at risk for additional primary tumors, and we may find that they need a molecular profile of their cancer before starting demethylating therapy,” said Joseph Califano, M.D., professor of otolaryngology-head and neck surgery and oncology at Johns Hopkins.

The findings, based on studies of normal and cancer cells from human mouth, nose and throat tissue, provide more evidence that important regulators of gene activity occur outside as well as inside DNA in a cell’s nucleus.

“While cancer-causing and other mutations alter vital protein-making pathways by rewriting the gene’s DNA code, epigenetic changes affect genes without changing the code itself. The new studies tell us that such changes occur not only when methyl groups bond to a gene’s on-off switch, but also when they come unglued,” said Califano.

He further said that sporadic reports of demethylation as a tool in activating cancer-promoting genes inspired them to develop a systematic way to discover these epigenetic changes and show how the process is linked to cancer.

For evidence, the researchers treated two cell lines from normal oral tissue with the demethylating drug 5-azacytidine and collected a list of genes that were activated as a result.

They used special silicon chips carrying pieces of genetic material that allow thousands of genes to be analysed at one time to locate genes activated by demethylation.

The list was cross-referenced with genes “turned on” in 49 head and neck cancer samples and 19 normal tissue samples.

Overall, researchers found 106 genes specific to head and neck cancer that were activated by the demethylation process.

“Some of the genes regulate growth, others metabolize sugars and some have already been linked to cancer development,” said Califano.

The findings of the study appear in the latest issue of PLoS One. (ANI)

Celebrate the Valentines with Taylor and Shroff wines

Mumbai, Feb 14 (ANI/Business Wire India): Taylor and Shroff ltd., a UK based company has recently launched its new range of wines in India. The brand Taylor and Shroff offers various flavors of wines – White Wine, Apricot Wine, Red Wine. The complete range of wines is inexpensive and can be enjoyed at any point of time.

The group has also created two wines exclusively for their customers to celebrate Valentines Day. They are Cherry wine and Ginger wine

Cherry wine is made especially for women to match their taste as the women enjoys soft and soothing drinks. The wine is prepared with cherry as that is considered to be one of the gentle fruit, giving wine a unique taste. Cherry wine has intense fruit flavor, it is sweeter in taste and can be easily consumed with the spicy Indian food. Cherry wine is Red in colour and matches the colour theme of Valentines.

Ginger wine is made especially for men, who have zest in them and want to lead their life with spunk, Ginger wine has a strong flavor in it and is different from other wines available in India and abroad. The wine has a unique flavor is not available with any other company in India. It also gives an amazing flavor when added with Whisky. So for Valentines Day it would be the perfect gift for men.

Speaking on the occasion Nainaz Shroff, MD Taylor and Shroff Group said, “We are delighted to be part of Indian wine industry. We see lot of potential in the market and we are planning to invest 5 million pounds in next 2 years. We are expecting a turnover of 34 million pounds in coming next 5 years”.

USP of Taylor and Shroff wines

The wines are fruity, luxuriously soft and delicious

All wines are best served as a chilled drink or poured over ice unlike many red wines

They are soft and sweet with low fruit acid and NO tannins

They both have good high Alcohols at 17 per cent to absorb rich spicy oily foods and freshen the pallet

The mouth feel is rich warm, sensuous and gulp able

All wines can be used to pour over Ice-cream, or to serve in fruit salads or Trifle Tipsy

These wines are wonderful for the chef to use in stir fries, dessert sauces and creams, savory gravies and sauces

These wines would last longer in your bar than most wines!!

These Wines contain ethyl alcohol and not methyl alcohol in them, which makes then more drinkable without the worry of a hangover and a headache the next day

Can be enjoyed chilled with Ice, unlike any other wine they have a distinct advantage of being enjoyed in many ways, such as serving over ice cream, trifle tipsy, desserts and may be used for cooking in a wide range of exotic sauces or mixed with other spirits to prepare cocktails. (ANI)